Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved

Fig. 3

Relationship between 18F-FDGal PET SUV and liver fat, fat-corrected liver weight and bodyweight Relationship between liver accumulated 2-[18F]fluoro-2-deoxy-D-galactose measured by positron emission tomography (PET) and expressed as SUV, and liver fat volume fraction (A), fat-corrected liver weight (B) and body weight (C) in early (orange) and late (red) non-alcoholic fatty liver disease animals and their respective control groups (green and blue)

Back to article page